金天保宁治疗恢复期脑梗死的临床研究

Efficacy of Taponing(ginkgo) on patients' recovery from cerebral infarction

目的观察金天保宁对恢复期脑梗死患者的临床疗效。方法将100例脑梗死恢复期患者随机分为治疗组和对照组各50例,对照组给予阿司匹林肠溶片0.1 qn,治疗组在上述基础上加用金天保宁1#tid。收集两组患者用药前及用药1个月、3个月及6个月后的神经功能缺损(NIHSS)评分数据。结果治疗后,治疗组NIHSS评分显著改善,且明显优于对照组(P<0.05)。治疗1月后、3月后、6月后的治疗组有效率分别为:96%、98%、98%,对照组有效率分别为:82%、84%、85.7%;治疗组3月内疗效改善显著优于对照组(P<0.05)。结论金天保宁有助于降低NIHSS评分,提高疗效,缩短疗程。

Objective To evaluate the effectiveness of Taponing（ginkgo） on the recovery from cerebral infarction. Method Firstly,100 cerebral infarction patients were randomly divided into an experimental group（n = 50） and a control group（n= 50）. The control group were given aspirin enteric coated tablets 0. 1g QN po. while the experimental group were given Taponing（ginkgo） 9. 6mg TID orally in addition to that given to the control group. The NIHSS scores of both groups as achieved before treatment and 1,3,6 months after treatment were then collected and analyzed. Findings After treatment,the experimental group achieved significantly better NIHSS scores than the control group（P〈0. 05）. The rates of effectiveness of the experimental group as observed 1 month,3 months,6 months after treatment were 96%,96% and98% respectively. Those of control group were 82%,84% and 85. 7%. The rate of effectiveness as observed in 3 months after treatment in the experimental group was significantly higher than that of the control group（P〈0. 05）. Conclusion Taponing can lower NIHSS scores,improve the efficacy and shorten the course of treatment.